Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Europese goedkeuring pembrolizumab voor behandeling van recidief of refractair klassiek HL
mei 2017 | Lymfoom